HTG Molecular Diagnostics Inc (STU:65H)
€ 0.242 0 (0%) Market Cap: 1,000.00 Enterprise Value: -2.44 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2018 HTG Molecular Diagnostics Inc Earnings Call Transcript

Mar 07, 2019 / 09:30PM GMT
Release Date Price: €405 (+0.90%)
Operator

Greetings, and welcome to the HTG Molecular Diagnostics Fourth Quarter and Full Year 2018 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Monique Kosse. Thank you. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

(technical difficulty)

HTG released financial results for the fourth quarter and year ended December 31, 2018.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including statements regarding the company's performance trends, growth of its RUO profiling business, activities expected to occur under the company's various collaborations and other agreements, planned product developments and launches and related expected benefits, expected benefits from pharma collaborations and revenue and operating expense expectations for 2019.

These forward-looking statements are subject to numerous risks and uncertainties,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot